Literature DB >> 23952897

Community-based treatment for opioid dependent offenders: a pilot study.

Randy Brown1, Michele Gassman, Scott Hetzel, Lisa Berger.   

Abstract

BACKGROUND: Primary care opioid substitution treatment (OST) has not been compared to program-based OST for community-supervised offenders.
OBJECTIVE: The purpose of this project was to compare primary care to specialist supervised OST for opioid dependent offenders in terms of substance use and HIV risk outcomes.
METHODS: This project randomly assigned 15 jail diversion participants to either: (i) primary care buprenorphine OST, (ii) specialist facility buprenorphine OST, or (iii) specialist facility methadone OST. Participation lasted 13.5 months (12-month active treatment plus a post-participation visit).
RESULTS: All subjects endorsed 0 days of opioid use in the previous 14 at follow-up. Specialty care reduced HIV risk (Risk Assessment Battery composite score) over 6 months (-.24 ± .17) compared to primary care (.02 ± .14; p = .032).
CONCLUSION: Findings support primary care OST feasibility for a community-supervised offender sample. Specialist care may facilitate improvements in secondary outcomes, such as HIV risk behaviors. SCIENTIFIC SIGNIFICANCE: Further research is needed to clarify (i) the role of primary care in addicted offender management, and (ii) the matching of offenders, based upon history and co-morbidity, to care coordination conditions.
Copyright © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23952897      PMCID: PMC3748386          DOI: 10.1111/j.1521-0391.2013.12049.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  6 in total

1.  Buprenorphine retention in primary care.

Authors:  Michael D Stein; Patricia Cioe; Peter D Friedmann
Journal:  J Gen Intern Med       Date:  2005-11       Impact factor: 5.128

2.  Increasing poisoning mortality rates in the United States, 1999-2006.

Authors:  Amy S B Bohnert; Sylwia Fudalej; Mark A Ilgen
Journal:  Public Health Rep       Date:  2010 Jul-Aug       Impact factor: 2.792

3.  Buprenorphine versus methadone maintenance for the treatment of opioid dependence.

Authors:  G Fischer; W Gombas; H Eder; R Jagsch; A Peternell; G Stühlinger; L Pezawas; H N Aschauer; S Kasper
Journal:  Addiction       Date:  1999-09       Impact factor: 6.526

4.  A long-term program of research on drug use and crime.

Authors:  D N Nurco
Journal:  Subst Use Misuse       Date:  1998-07       Impact factor: 2.164

5.  Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study.

Authors:  Michael Soyka; Christina Zingg; Gabriele Koller; Heinrich Kuefner
Journal:  Int J Neuropsychopharmacol       Date:  2008-01-21       Impact factor: 5.176

6.  The Fifth Edition of the Addiction Severity Index.

Authors:  A T McLellan; H Kushner; D Metzger; R Peters; I Smith; G Grissom; H Pettinati; M Argeriou
Journal:  J Subst Abuse Treat       Date:  1992
  6 in total
  7 in total

Review 1.  HIV prevention for adults with criminal justice involvement: a systematic review of HIV risk-reduction interventions in incarceration and community settings.

Authors:  Kristen Underhill; Dora Dumont; Don Operario
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

Review 2.  Leveraging the U.S. Criminal Justice System to Access Women for HIV Interventions.

Authors:  Jaimie P Meyer; Dharushana Muthulingam; Nabila El-Bassel; Frederick L Altice
Journal:  AIDS Behav       Date:  2017-12

Review 3.  Primary care models for treating opioid use disorders: What actually works? A systematic review.

Authors:  Pooja Lagisetty; Katarzyna Klasa; Christopher Bush; Michele Heisler; Vineet Chopra; Amy Bohnert
Journal:  PLoS One       Date:  2017-10-17       Impact factor: 3.240

Review 4.  Substance misuse and community supervision: A systematic review of the literature.

Authors:  Coral Sirdifield; Charlie Brooker; Rebecca Marples
Journal:  Forensic Sci Int Mind Law       Date:  2020-11

5.  Interventions for female drug-using offenders.

Authors:  Amanda E Perry; Marrissa Martyn-St James; Lucy Burns; Catherine Hewitt; Julie M Glanville; Anne Aboaja; Pratish Thakkar; Keshava Murthy Santosh Kumar; Caroline Pearson; Kath Wright
Journal:  Cochrane Database Syst Rev       Date:  2019-12-13

Review 6.  Interventions for drug-using offenders with co-occurring mental health problems.

Authors:  Amanda E Perry; Marrissa Martyn-St James; Lucy Burns; Catherine Hewitt; Julie M Glanville; Anne Aboaja; Pratish Thakkar; Keshava Murthy Santosh Kumar; Caroline Pearson; Kath Wright; Shilpi Swami
Journal:  Cochrane Database Syst Rev       Date:  2019-10-07

7.  The effectiveness of a group-based computerized HIV/STI prevention intervention for black women who use drugs in the criminal justice system: study protocol for E-WORTH (Empowering African-American Women on the Road to Health), a Hybrid Type 1 randomized controlled trial.

Authors:  Karen Johnson; Louisa Gilbert; Timothy Hunt; Elwin Wu; Lisa Metsch; Dawn Goddard-Eckrich; Stanley Richards; Rick Tibbetts; Jessica C Rowe; Milton L Wainberg; Nabila El-Bassel
Journal:  Trials       Date:  2018-09-10       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.